| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Chief Executive Officer
3 companies
Perry Michael S is a Director at ARMP with holdings across 3 companies. Recent SEC Form 4 filings include 0 buys and 16 sells.
Estimated insider holdings value: $14.9M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 5, 2025 | ARWR Arrowhead Pharmaceuticals, Inc. | Director | Sell | 16,250 | $61.03 | $991,737.50 | -12.4% | +3.5% | - | |
| Nov 21, 2022 | RCEL Avita Medical, Inc. | Director | Sale+OE | 150,000 | $7.18 | $1,077,000.00 | -39.5% | +27.0% | +41.6% | |
| Feb 24, 2022 | RCEL Avita Medical, Inc. | Chief Executive Officer | Sell | 10,812 | $8.74 | $94,496.88 | -3.3% | -39.2% | +38.2% | |
| Jan 3, 2022 | ARWR Arrowhead Pharmaceuticals, Inc. | Director | Sell | 4,500 | $64.71 | $291,192.40 | -1.7% | -27.7% | -45.0% | |
| Sep 1, 2021 | RCEL Avita Medical, Inc. | Chief Executive Officer | Sell | 11,220 | $20.68 | $232,029.60 | -4.5% | -33.9% | -70.3% | |
| Jun 2, 2021 | RCEL Avita Medical, Inc. | Chief Executive Officer | Sell | 23,000 | $17.33 | $398,590.00 | -9.3% | +16.6% | -67.1% | |
| Jan 4, 2021 | ARWR Arrowhead Pharmaceuticals, Inc. | Director | Sell | 4,000 | $76.09 | $304,360.00 | -4.3% | - | - | |
| Sep 16, 2020 | RCEL Avita Medical, Inc. | Chief Executive Officer | Sell | 47,861 | $27.19 | $1,301,252.95 | -3.5% | - | - | |
| Sep 11, 2020 | RCEL Avita Medical, Inc. | Chief Executive Officer | Sell | 27,128 | $26.08 | $707,581.28 | -3.2% | - | - | |
| May 12, 2020 | ARWR Arrowhead Pharmaceuticals, Inc. | Director | Sell | 36,000 | $35.83 | $1,289,891.00 | -62.0% | - | - |